Adolescent nicotine induces depressive and anxiogenic effects through ERK 1-2 and Akt-GSK-3 pathways and neuronal dysregulation in the nucleus accumbens.

Addiction Biology
Roger HudsonSteven R Laviolette

Abstract

Long-term tobacco dependence typically develops during adolescence and neurodevelopmental nicotine exposure is associated with affective disturbances that manifest as a variety of neuropsychiatric comorbidities in clinical and preclinical studies, including mood and anxiety-related disorders. The nucleus accumbens shell (NASh) is critically involved in regulating emotional processing, and both molecular and neuronal disturbances in this structure are associated with mood and anxiety-related pathologies. In the present study, we used a rodent model of adolescent neurodevelopmental nicotine exposure to examine the expression of several molecular biomarkers associated with mood/anxiety-related phenotypes. We report that nicotine exposure during adolescence (but not adulthood) induces profound upregulation of the ERK 1-2 and Akt-GSK-3 signalling pathways directly within the NASh, as well as downregulation of local D1R expression that persists into adulthood. These adaptations were accompanied by decreases in τ, α, β, and γ-band oscillatory states, hyperactive medium spiny neuron activity with depressed bursting rates, and anxiety and depressive-like behavioural abnormalities. Pharmacologically targeting these molecular and neuronal...Continue Reading

References

May 1, 1989·Pharmacology, Biochemistry, and Behavior·Y K Fung, Y S Lau
Apr 27, 1987·Life Sciences·L C MurrinN J Haley
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·P S Klein, D A Melton
Sep 3, 2004·The Journal of Clinical Investigation·Kamal RahmouniWilliam G Haynes
Sep 15, 2004·Neuron·Joshua D BerkeHoward B Eichenbaum
Jun 27, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Danielle S CounotteTommy Pattij
Aug 8, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Steven R LavioletteHuibing Tan
Oct 24, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Dara M CannonWayne C Drevets
Apr 9, 2009·PloS One·Aaron J GruberPatricio O'Donnell
Apr 24, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Clinton B McCracken, Anthony A Grace
Jun 12, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michael X CohenThomas E Schlaepfer
Jul 21, 2009·Neuroreport·Elizabeth A OsuchRichard W J Neufeld
Sep 1, 2009·The Psychiatric Clinics of North America·Katja BeesdoDaniel S Pine
Apr 8, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Joshua T MorraJoseph F Cheer
Jun 2, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Joseph M BodenL John Horwood
May 10, 2011·Biological Psychiatry·Jérémie NeastaDorit Ron
Sep 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Mark W HoweAnn M Graybiel
Oct 18, 2012·Proceedings of the National Academy of Sciences of the United States of America·Nuné LemaireAnn M Graybiel
Nov 24, 2012·Hormones and Behavior·Cheryl M McCormickRachel A Clark
Mar 8, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Maciej OlszewskiMark J Hunt
May 21, 2013·Physiology & Behavior·Olena V BogdanovaPerry F Renshaw
May 25, 2013·Journal of the American Academy of Child and Adolescent Psychiatry·Vilma GabbayMichael P Milham
Sep 13, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Danika LyonsSteven R Laviolette
Apr 2, 2014·Journal of Cell Science·Ulrich MaurerCéline Charvet
Jun 5, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ninglei SunUNKNOWN Addiction Research Group
Oct 24, 2014·The Journal of Biological Chemistry·Meenalakshmi M MariappanBalakuntalam S Kasinath
Mar 4, 2015·ELife·Jonas-Frederic SauerMarlene Bartos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.